Ulcerative Colitis Study: Correlation of Faecal Calprotectin with Histological Nancy Index

BÜHLMANN IBDoc®:

Walsh, A, Kormilitzin, A. et al. New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC).  13th Congress of ECCO 2018, Feb 14 – 17, 2018. Vienna, Austria.

Highlights from this Poster

“Conclusions. An FCal <180 g/g is indicative of endoscopic and histological remission. FCal may act as a reliable marker of mucosal healing, replacing the need for endoscopy in some patients.”

Read Citation

Health Canada Licence: 98903, Device class: 3 

BÜHLMANN IBDoc® is Not Available for Sale in the US.